BridgeBio Pharma, Inc. (BBIO)

65.34 -1.14 (-1.71%) USD  |  NASDAQ  |  Mar 02, 15:57
More

BridgeBio Pharma Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Mirum Pharmaceuticals, Inc. Upgrade
Alphatec Holdings, Inc. Upgrade
Supernus Pharmaceuticals, Inc. Upgrade
Cogent Biosciences, Inc. Upgrade